Product Information
TRICITRATES ORAL SOLUTION is a generic product labeled by Chartwell RX LLC, priced at $0.0314 per ML under NDC 62135043847. Its NADAC has been published 146 times since Dec 20, 2023.
Strength
334; 550; 500 mg/5mL; mg/5mL; mg/5mL
Manufacturer
Chartwell RX LLCNDC
62135043847
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE; SODIUM CITRATEApproval Type
Unapproved
On Market Since
12/8/2022
Pharmacological Classes
Price Statistics
The NADAC for TRICITRATES ORAL SOLUTION has been published 146 times since Dec 20, 2023, and over the history we have for it it has risen 9.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0314 per ML |
|---|---|
| All-time high | $0.0364 (Jul 15, 2026) |
| All-time low | $0.0279 (May 22, 2024) |
| 52-week high | $0.0364 |
| 52-week low | $0.0298 |
| Median price | $0.0318 |
| Average price | $0.0319 |
| Largest weekly change | +18.7% (Jun 19, 2024) |
| Weeks tracked | 146 |
| Tracking since | Dec 20, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Tricitrates market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tricitrates market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-coagulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRICITRATES ORAL SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for TRICITRATES ORAL SOLUTION, manufactured by Chartwell RX LLC, is $0.0314 per ML (NDC 62135043847), effective Sep 30, 2026.
How has the price of TRICITRATES ORAL SOLUTION changed over time?
Over the history we have for it, the NADAC for TRICITRATES ORAL SOLUTION has risen 9.4%. It has been tracked across 146 weekly CMS publications since Dec 20, 2023.
What are the highest and lowest recorded NADAC prices for TRICITRATES ORAL SOLUTION?
Since Dec 20, 2023, the NADAC for TRICITRATES ORAL SOLUTION has ranged from a low of $0.0279 (May 22, 2024) to a high of $0.0364 (Jul 15, 2026), with a median of $0.0318 per ML.
Are there cheaper alternatives to TRICITRATES ORAL SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of TRICITRATES ORAL SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRICITRATES ORAL SOLUTION?
TRICITRATES ORAL SOLUTION (NDC 62135043847) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.